======= RIPK1 ======= == Gene Information == * **Official Symbol**: RIPK1 * **Official Name**: receptor interacting serine/threonine kinase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8737|8737]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13546|Q13546]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RIPK1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RIPK1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603453|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Serine-threonine kinase which transduces inflammatory and cell-death signals (programmed necrosis) following death receptors ligation, activation of pathogen recognition receptors (PRRs), and DNA damage. Upon activation of TNFR1 by the TNF-alpha family cytokines, TRADD and TRAF2 are recruited to the receptor. Phosphorylates DAB2IP at 'Ser-728' in a TNF-alpha-dependent manner, and thereby activates the MAP3K5-JNK apoptotic cascade. Ubiquitination by TRAF2 via 'Lys-63'-link chains acts as a critical enhancer of communication with downstream signal transducers in the mitogen-activated protein kinase pathway and the NF-kappa-B pathway, which in turn mediate downstream events including the activation of genes encoding inflammatory molecules. Polyubiquitinated protein binds to IKBKG/NEMO, the regulatory subunit of the IKK complex, a critical event for NF-kappa-B activation. Interaction with other cellular RHIM-containing adapters initiates gene activation and cell death. RIPK1 and RIPK3 association, in particular, forms a necrosis-inducing complex. {ECO:0000269|PubMed:11101870, ECO:0000269|PubMed:17389591, ECO:0000269|PubMed:19524512, ECO:0000269|PubMed:19524513}. |Pkinase| |RHIM| |Pkinase Tyr| |Death| |regulation of ATP:ADP antiporter activity| |ripoptosome assembly involved in necroptotic process| |ripoptosome assembly| |positive regulation of necroptotic process| |positive regulation of programmed necrotic cell death| |death domain binding| |positive regulation of hydrogen peroxide-induced cell death| |ripoptosome| |necroptotic signaling pathway| |death-inducing signaling complex| |positive regulation of response to reactive oxygen species| |peptidyl-serine autophosphorylation| |death-inducing signaling complex assembly| |positive regulation of necrotic cell death| |JUN kinase kinase kinase activity| |amyloid fibril formation| |positive regulation of tumor necrosis factor-mediated signaling pathway| |positive regulation of production of miRNAs involved in gene silencing by miRNA| |positive regulation of cellular response to drug| |toll-like receptor 3 signaling pathway| |activation of JNKK activity| |negative regulation of cardiac muscle cell proliferation| |T cell apoptotic process| |positive regulation of macrophage differentiation| |positive regulation of oxidative stress-induced cell death| |death receptor binding| |regulation of nucleobase-containing compound transport| |regulation of necroptotic process| |positive regulation of cellular response to oxidative stress| |lymphocyte apoptotic process| |regulation of production of miRNAs involved in gene silencing by miRNA| |positive regulation of response to oxidative stress| |regulation of production of small RNA involved in gene silencing by RNA| |regulation of programmed necrotic cell death| |regulation of macrophage differentiation| |regulation of hydrogen peroxide-induced cell death| |necroptotic process| |positive regulation of gene silencing by miRNA| |negative regulation of heart growth| |negative regulation of cardiac muscle tissue growth| |leukocyte apoptotic process| |positive regulation of posttranscriptional gene silencing| |regulation of anion transmembrane transport| |programmed necrotic cell death| |TRIF-dependent toll-like receptor signaling pathway| |regulation of necrotic cell death| |necrotic cell death| |positive regulation of response to drug| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |MyD88-independent toll-like receptor signaling pathway| |regulation of response to reactive oxygen species| |negative regulation of extrinsic apoptotic signaling pathway in absence of ligand| |regulation of cellular response to drug| |negative regulation of signal transduction in absence of ligand| |negative regulation of extrinsic apoptotic signaling pathway via death domain receptors| |activation of JUN kinase activity| |regulation of cardiac muscle cell proliferation| |negative regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of extrinsic apoptotic signaling pathway in absence of ligand| |negative regulation of striated muscle tissue development| |positive regulation of interleukin-8 production| |positive regulation of extrinsic apoptotic signaling pathway| |negative regulation of muscle organ development| |positive regulation of cytokine-mediated signaling pathway| |negative regulation of muscle tissue development| |activation of MAPKK activity| |positive regulation of myeloid leukocyte differentiation| |regulation of extrinsic apoptotic signaling pathway via death domain receptors| |positive regulation of response to cytokine stimulus| |regulation of cardiac muscle tissue growth| |regulation of tumor necrosis factor-mediated signaling pathway| |regulation of oxidative stress-induced cell death| |regulation of heart growth| |regulation of interleukin-8 production| |I-kappaB kinase/NF-kappaB signaling| |cellular response to hydrogen peroxide| |positive regulation of JUN kinase activity| |regulation of cellular response to oxidative stress| |regulation of cardiac muscle tissue development| |JNK cascade| |regulation of response to oxidative stress| |positive regulation of tumor necrosis factor production| |regulation of gene silencing by miRNA| |regulation of JUN kinase activity| |activation of cysteine-type endopeptidase activity involved in apoptotic process| |positive regulation of tumor necrosis factor superfamily cytokine production| |regulation of gene silencing by RNA| |regulation of posttranscriptional gene silencing| |positive regulation of myeloid cell differentiation| |regulation of organ growth| |positive regulation of reactive oxygen species metabolic process| |regulation of anion transport| |extrinsic apoptotic signaling pathway| |toll-like receptor signaling pathway| |regulation of response to drug| |negative regulation of extrinsic apoptotic signaling pathway| |negative regulation of G1/S transition of mitotic cell cycle| |negative regulation of developmental growth| |stress-activated MAPK cascade| |negative regulation of cell cycle G1/S phase transition| |protein heterooligomerization| |regulation of myeloid leukocyte differentiation| |cellular response to antibiotic| |tumor necrosis factor-mediated signaling pathway| |response to hydrogen peroxide| |pattern recognition receptor signaling pathway| |regulation of gene silencing| |cellular response to reactive oxygen species| |regulation of striated muscle tissue development| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of muscle tissue development| |regulation of muscle organ development| |positive regulation of JNK cascade| |stress-activated protein kinase signaling cascade| |positive regulation of leukocyte differentiation| |regulation of tumor necrosis factor production| |regulation of G1/S transition of mitotic cell cycle| |positive regulation of cysteine-type endopeptidase activity| |regulation of tumor necrosis factor superfamily cytokine production| |positive regulation of NF-kappaB transcription factor activity| |regulation of extrinsic apoptotic signaling pathway| |activation of MAPK activity| |regulation of cytokine-mediated signaling pathway| |regulation of cell cycle G1/S phase transition| |positive regulation of stress-activated MAPK cascade| |positive regulation of stress-activated protein kinase signaling cascade| |positive regulation of endopeptidase activity| |peptidyl-serine phosphorylation| |positive regulation of apoptotic signaling pathway| |regulation of response to cytokine stimulus| |regulation of reactive oxygen species metabolic process| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of JNK cascade| |positive regulation of hemopoiesis| |positive regulation of peptidase activity| |protein autophosphorylation| |response to reactive oxygen species| |peptidyl-serine modification| |receptor complex| |negative regulation of mitotic cell cycle phase transition| |endosome membrane| |cellular response to toxic substance| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |membrane raft| |negative regulation of apoptotic signaling pathway| |regulation of myeloid cell differentiation| |negative regulation of cell cycle phase transition| |innate immune response-activating signal transduction| |regulation of stress-activated MAPK cascade| |regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of stress-activated protein kinase signaling cascade| |protein kinase activity| |cellular response to oxidative stress| |cellular response to tumor necrosis factor| |regulation of cysteine-type endopeptidase activity| |negative regulation of growth| |activation of innate immune response| |regulation of ion transmembrane transporter activity| |positive regulation of DNA-binding transcription factor activity| |positive regulation of MAP kinase activity| |response to tumor necrosis factor| |regulation of transmembrane transporter activity| |protein-containing complex binding| |regulation of leukocyte differentiation| |regulation of transporter activity| |protein deubiquitination| |apoptotic signaling pathway| |ubiquitin protein ligase binding| |protein modification by small protein removal| |response to antibiotic| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |activation of protein kinase activity| |regulation of developmental growth| |positive regulation of protein serine/threonine kinase activity| |protein homooligomerization| |positive regulation of innate immune response| |regulation of MAP kinase activity| |positive regulation of proteolysis| |positive regulation of response to biotic stimulus| |protein serine/threonine kinase activity| |MAPK cascade| |response to oxidative stress| |signal transduction by protein phosphorylation| |regulation of apoptotic signaling pathway| |cellular response to drug| |regulation of mitotic cell cycle phase transition| |regulation of endopeptidase activity| |regulation of DNA-binding transcription factor activity| |regulation of peptidase activity| |regulation of cell cycle phase transition| |positive regulation of cytokine production| |regulation of hemopoiesis| |regulation of innate immune response| |supramolecular fiber organization| |positive regulation of defense response| |regulation of ion transmembrane transport| |cellular response to growth factor stimulus| |response to toxic substance| |negative regulation of intracellular signal transduction| |positive regulation of multi-organism process| |regulation of protein serine/threonine kinase activity| |protein complex oligomerization| |regulation of response to biotic stimulus| |response to growth factor| |response to inorganic substance| |positive regulation of protein kinase activity| |positive regulation of MAPK cascade| |immune response-activating signal transduction| |regulation of transmembrane transport| |negative regulation of cell cycle| |positive regulation of kinase activity| |immune response-regulating signaling pathway| |positive regulation of response to external stimulus| |cellular protein catabolic process| |activation of immune response| |regulation of mitotic cell cycle| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of transferase activity| |regulation of growth| |cytokine-mediated signaling pathway| |negative regulation of cell population proliferation| |protein catabolic process| |regulation of cytokine production| |positive regulation of cell death| |regulation of ion transport| |viral process| |regulation of proteolysis| |regulation of cellular response to stress| |regulation of cell cycle process| |regulation of MAPK cascade| |regulation of defense response| |positive regulation of hydrolase activity| |regulation of multi-organism process| |symbiotic process| |regulation of protein kinase activity| |interspecies interaction between organisms| |positive regulation of immune response| |regulation of kinase activity| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |cellular macromolecule catabolic process| |negative regulation of programmed cell death| |apoptotic process| |negative regulation of developmental process| |positive regulation of cell differentiation| |protein phosphorylation| |regulation of transferase activity| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |cellular response to cytokine stimulus| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |response to drug| |macromolecule catabolic process| |programmed cell death| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |organonitrogen compound catabolic process| |identical protein binding| |cell death| |regulation of response to external stimulus| |response to cytokine| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |regulation of immune response| |positive regulation of immune system process| |regulation of cell cycle| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |mitochondrion| |negative regulation of signal transduction| |proteolysis| |regulation of hydrolase activity| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of response to stress| |ATP binding| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |organic substance catabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-2.43| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.15| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.05| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.75| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.41| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5387 * **Expression level (log2 read counts)**: 4.96 {{:chemogenomics:nalm6 dist.png?nolink |}}